Results 11 to 20 of about 2,851,507 (299)

Initiation of triple therapy maintenance treatment among patients with COPD in the US

open access: yesInternational Journal of COPD, 2016
Jason C Simeone,1 Rakesh Luthra,2 Shuchita Kaila,2 Xiaoyun Pan,1 Tarun D Bhagnani,1 Jieruo Liu,1 Teresa K Wilcox1 1Real-World Evidence, Evidera, Waltham, MA, 2HEOR Value Demonstration Team, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA
Simeone JC   +6 more
doaj   +1 more source

Effectiveness and Safety of Dual Versus Triple Antibiotic Therapy for Treating Brucellosis Infection: A Retrospective Cohort Study

open access: yesAntibiotics
Background: Brucellosis is a major zoonotic infection that warrants treatment with antibiotic therapy. Current treatment recommendations include using either dual or triple therapy with antibiotics active against brucella species.
Yazed Saleh Alsowaida   +8 more
doaj   +2 more sources

Guidelines for mono, double and triple antithrombotic therapy [PDF]

open access: yes, 2021
Guidelines for antithrombotic therapy are complex, especially if a patient has several indications that require antithrombotic therapy. In general, no patient should receive lifelong double or triple antithrombotic therapy.
Patricia M L A van den Bemt   +12 more
core   +2 more sources

Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease

open access: yesPulmonary Therapy, 2020
Introduction Maintenance treatment strategies in COPD recommend inhaled corticosteroid (ICS) + long-acting muscarinic antagonist (LAMA) + long-acting β2-agonist (LABA) triple therapy after initial dual therapy.
Jennifer K. Quint   +8 more
doaj   +1 more source

The Triple Challenge of Triple Therapy

open access: yesJACC: Cardiovascular Interventions, 2016
The addition of dual antiplatelet (DAPT) therapy to oral anticoagulant triples the risk of major bleeding complications [(1–4)][1]. Patients who are exposed to triple therapy should be considered at high risk for bleeding given the fact that, in addition to the risk of triple therapy itself ...
Jean-Philippe, Collet   +2 more
openaire   +2 more sources

Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety

open access: yesCOPD, 2022
Triple therapy for chronic obstructive pulmonary disease (COPD) is recommended for some patients, but the inhaled corticosteroids (ICS) may differ in effectiveness and safety. We compared budesonide-based and fluticasone-based triple therapy given in two
Samy Suissa   +2 more
doaj   +1 more source

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma

open access: yesBMC Pulmonary Medicine, 2021
Background An important proportion of asthma patients remain uncontrolled despite using inhaled corticosteroids and long-acting beta-agonists. Clinical guidelines recommend, in these patients, using add-on long-acting muscarinic antagonists (triple ...
Jefferson Antonio Buendía   +1 more
doaj   +1 more source

Triple F Utvecklingsplan : Version 1

open access: yes, 2021
Triple F (Fossil Free Freight) är ett nationellt forsknings- och innovationsprogram med syfte att utveckla kunskap som kan bidra till att minska godstransporternas växthusgasutsläpp i Sverige. Programmet finansieras av Trafikverket.
Blidberg, Nicklas   +2 more
core   +1 more source

Lenvatinib combined with anti-PD-1 antibodies plus transcatheter arterial chemoembolization for neoadjuvant treatment of resectable hepatocellular carcinoma with high risk of recurrence: A multicenter retrospective study

open access: yesFrontiers in Oncology, 2022
BackgroundEarly recurrence is common after surgical resection (SR) for hepatocellular carcinoma (HCC) with high risk of recurrence and is associated with poor prognosis.
Jun-Yi Wu   +15 more
doaj   +1 more source

A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease

open access: yesInternational Journal of COPD, 2021
Wei-Chun Huang,1,2 Chih-Yu Chen,1 Wei-Chih Liao,1,2 Biing-Ru Wu,1,3,4 Wei-Chun Chen,1,3,4 Chih-Yen Tu,1,2 Chia-Hung Chen,1,2 Wen-Chien Cheng1– 4 1Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University ...
Huang WC   +7 more
doaj  

Home - About - Disclaimer - Privacy